Takeda Pharmaceutical (TAK) Other Operating Expenses (2019 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Other Operating Expenses of -$14.4 billion for Q1 2026, up 8.14% year-over-year from -$13.3 billion in Q1 2025, and down 1467.87% quarter-over-quarter from $1.1 billion in Q4 2025.
Takeda Pharmaceutical (TAK) Other Operating Expenses (2019 - 2026) Analysis & Trends
Takeda Pharmaceutical's Other Operating Expenses history runs 7 years deep, the most recent figure standing at -$14.4 billion for Q1 2026.
- In Q1 2026, Other Operating Expenses rose 8.14% year-over-year to -$14.4 billion; the TTM figure through Jun 2026 stood at -$16.0 billion (up 1.49% YoY), while the FY2026 annual figure was -$6.6 billion, up 6.66% from the prior year.
- Other Operating Expenses for Q1 2026 stood at -$14.4 billion, down from $1.1 billion in the prior quarter.
- The five-year high for Other Operating Expenses was $1.3 billion in Q4 2022, with the low at -$16.1 billion in Q1 2024.
- The 5-year median for Other Operating Expenses is $930.8 million (2024), against an average of -$2.9 billion.
- The sharpest annual moves came in 2023 and 2024: Other Operating Expenses climbed 17.86% in 2023, then plunged 1409.64% in 2024.
- Takeda Pharmaceutical's Other Operating Expenses stood at $1.3 billion in 2022, then declined by 10.94% to $1.1 billion in 2023, then retreated by 16.99% to $953.0 million in 2024, then gained by 10.54% to $1.1 billion in 2025, then slumped by 1467.87% to -$14.4 billion in 2026.
- Business Quant data shows TAK's Other Operating Expenses at -$14.4 billion in Q1 2026, $1.1 billion in Q4 2025, and -$2.7 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.31 Bn | 39.66 Bn | 2.15 Bn |
| 3 | Zoetis | 31.65 Bn | 29.98 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.18 Bn | 19.52 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.94 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.70 Bn | 15.31 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.41 Bn |
| Dec 31, 2025 | 1.05 Bn |
| Sep 30, 2025 | -2.67 Bn |
| Jun 30, 2025 | 908.64 Mn |
| Mar 31, 2025 | -15.69 Bn |
| Dec 31, 2024 | 952.99 Mn |
| Sep 30, 2024 | -2.45 Bn |
| Jun 30, 2024 | 1.09 Bn |
| Mar 31, 2024 | -16.11 Bn |
| Dec 31, 2023 | 1.15 Bn |
| Sep 30, 2023 | -2.30 Bn |
| Jun 30, 2023 | 1.15 Bn |
| Mar 31, 2023 | 1.23 Bn |
| Dec 31, 2022 | 1.29 Bn |
| Sep 30, 2022 | -2.46 Bn |
| Jun 30, 2022 | 977.27 Mn |
| Sep 30, 2020 | -3.55 Bn |
| Mar 31, 2020 | -16.64 Bn |
| Mar 31, 2019 | -360.86 Mn |